EXHIBIT 99.1

FINANCIAL STATEMENTS

Table of Contents

Page
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM..................... 1
ECHELON ACQUISITION CORP.................................................... 3
BALANCE SHEET............................................................... 3
STATEMENTS OF OPERATIONS.................................................... 4
STATEMENTS OF SHAREHOLDERS' EQUITY.......................................... 5
STATEMENTS OF CASH FLOWS.................................................... 6
NOTES TO FINANCIAL STATEMETNS............................................... 7
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.................... 12
ASIA BIOTECHNOLOGY GROUP INC............................................... 13
CONSOLIDATED BALANCE SHEET................................................. 13
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS............... 14
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY............................. 15
CONSOLIDATED STATEMENT OF CASH FLOW........................................ 16
NOTES TO FINANCIAL STATEMENTS.............................................. 17

Child, Van Wagoner & Bradshaw, PLLC
A PROFESSIONAL LIMITED LIABILITY COMPANY OF CERTIFIED PUBLIC ACCOUNTANTS
5296 S. Commerce Dr., Suite 300, Salt Lake City, UT 84107
PHONE: (801) 281-4700 FAX: (801) 281-4701

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To The Board of Directors
Echelon Acquisition Corp.

We have audited the accompanying balance sheet of Echelon Acquisition Corp. as
of December 31, 2005, and the related statements of operations, shareholders'
equity (deficit), and cash flows for the year ended December 31, 2005 and for
the period from July 27, 2004 (inception) to December 31, 2004. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.

We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States of America). Those standards require
that we plan and perform the audits to obtain reasonable assurance about
whether the financial statements are free of material misstatement. The Company
is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. Our audits included consideration of
internal control over financial reporting, as a basis for designing audit
procedures that are appropriate in the circumstances, but not for the purpose
of expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. Accordingly, we express no such opinion. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by management, as
well as evaluating the overall financial statement presentation. We believe
that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Echelon Acquisition Corp. as
of December 31, 2005, and the results of its operations and its cash flows for
the year ended December 31, 2005 and for the period from July 27, 2004
(inception) to December 31, 2004, in conformity with accounting principles
generally accepted in the United States of America.

Child, Van Wagoner & Bradshaw, PLLC
Salt Lake City, Utah
May 8, 2006

ECHELON ACQUISITION CORP.
(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEET

December 31,
2005

ASSETS

Current assets:
Cash and cash equivalents $ -
------------
Total assets $ -
============

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities:
Accrued liabilities $ 800
------------
Total current liabilities 800
------------
Total liabilities 800

Shareholders' deficit:
Preferred Stock at $0.001 par value; authorized
20,000,000 shares; no shares issued and
outstanding -
Common stock at $0.001 par value; authorized 11,648
100,000,000 shares; 11,648,000 shares issued
and outstanding
Deficit accumulated during the development stage (12,448)
------------
Total shareholders' deficit (800)
------------
Total liabilities and shareholders' deficit $ -
============

See accompanying notes to financial statements.

ECHELON ACQUISITION CORP.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS

For the Year Period from Period from
ended July 27, 2004 July 27, 2004
December (inception) to (inception) to
31, December 31, December 31,
2005 2004 2005
------------- -------------- --------------

Revenue $ - $ - $ -

General and administrative
Organization and related expenses - 148 148
General and administrative expenses 11,500 800 12,300
------------- -------------- --------------
Total general and administrative 11,500 948 12,448
------------- -------------- --------------

Net loss $ (11,500) $ (948) $ (12,448)
============= ============== ==============
Net loss per share
- - basic and fully diluted $ (0.00) $ (0.01)
============= ==============

Weighted average ordinary shares
outstanding
- - basic and fully diluted 9,946,630 148,000
============= ==============

See accompanying notes to financial statements.

ECHELON ACQUISITION CORP.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF SHAREHOLDERS' EQUITY

Acculmulated other Total
Ordinary Share Additional Share-
-------------------
Shares Paid-in Accumulated Comprehensive holder'
Outstanding Amount Capital Deficit Income Equity
----------- ------- ---------- ----------- ------------- ---------

Shares issued to founder for organization cost and 148,000 $ 148 $ - $ - $ - $ 148
services on July 27, 2004
(inception)
Net loss - (948) - (948)
----------- ------- ---------- ----------- ------------- ---------
Balance at December 31, 2004 148,000 148 - (948) - (800)

Shares issued for services 11,500,000 11,500 - - 11,500
rendered on February 23,
2005

Net loss (11,500) - (11,500)
----------- ------- ---------- ----------- ------------- ---------
Balance at December 31, 2005 11,648,000 $11,648 $ - $ (12,448) $ - $ (800)
=========== ======= ========== =========== ============= =========

See accompanying notes to financial statements.

ECHELON ACQUISITION CORP.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS

For the Year Period from Period from
ended July 27, 2004 July 27, 2004
December (inception) to (inception) to
31, December 31, December 31,
2005 2004 2005
------------- -------------- --------------

Cash flows from operating activities
Net loss $ (11,500) $ (948) $ (12,448)
Issuance of stock for services rendered 11,500 148 11,648
Increase in accrued liabilities - 800 800
------------- -------------- --------------
Net cash generated from operating activities - - -

Cash flows from investing activities - - -

Cash flows from financing activities - - -
------------- -------------- --------------

Net increase (decrease) in cash and cash - - -
equivalents
Cash and cash equivalents, beginning of year - - -
------------- -------------- --------------
Cash and cash equivalents, end of year $ - $ - $ -
============= ============== ==============

Supplementary disclosures of cash flow
information:
Cash paid (refund) during the year for:
Interest $ - $ - $ -
Income taxes $ - $ - $ -

See accompanying notes to financial statements.

NOTE 1 BUSINESS DESCRIPTION AND ORGANIZATION

Echelon Acquisition Corp. ("EAC" or the "Company") was incorporated under the
laws of the State of Delaware on July 27, 2004 and has been inactive since
inception. The Company intends to serve as a vehicle to effect an asset
acquisition, merger, exchange of capital stock or other business combination
with a domestic or foreign business.

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - Development Stage Company

The Company has not earned any revenue from operations. Accordingly, the
Company's activities have been accounted for as those of a "Development Stage
Enterprise" as set forth in Financial Accounting Standards Board Statement No.
7 ("SFAS 7"). Among the disclosures required by SFAS 7 are that the Company's
financial statements be identified as those of a development stage company, and
that the statements of operations, stockholders' equity and cash flows disclose
activity since the date of the Company's inception.

A. Accounting Method

The Company's financial statements are prepared using the accrual method of
accounting. The Company has elected a fiscal year ending on December 31.

B. Cash and cash equivalents

Cash and cash equivalents include cash on hand, cash accounts, interest bearing
savings accounts and time certificates of deposit with a maturity of three
months or less when purchased.

C. Foreign currency translation

Transactions and balances originally denominated in U.S. dollars are presented
at their original amounts. Transactions and balances in other currencies are
converted into U.S. dollars in accordance with Statement of Financial
Accounting Standards (SFAS) No. 52, "Foreign Currency Translation," and are
included in determining net income or loss.

For foreign operations with the local currency as the functional currency,
assets and liabilities are translated from the local currencies into U.S.
dollars at the exchange rate prevailing at the balance sheet date. Revenues,
expenses and cash flows are translated at the average exchange rate for the
period to approximate translation at the exchange rate prevailing at the dates
those elements are recognized in the financial statements. Translation
adjustments resulting from the process of translating the local currency
financial statements into U.S. dollars are included in determining
comprehensive loss.

D. Use of estimates

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosures of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.

A. Significant Estimates

Several areas require management's estimates relating to uncertainties for
which it is reasonably possible that there will be a material change in the
near term. The more significant areas requiring the use of management estimates
related to valuation of the useful lives of the Company's equipment and
valuation of contingent liabilities and the valuation of stock issued for
services.

F. Income Taxes

The Company accounts for income taxes under the Financial Accounting
Standards Board (FASB) Statement No. 109, "Accounting for Income Taxes"
"Statement 109"). Under Statement 109, deferred tax assets and liabilities are
recognized for the future tax consequences attributable to differences between
the financial statement carrying amounts of existing assets and liabilities and
their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered or settled.
Under Statement 109, the effect on deferred tax assets and liabilities of a
change in tax rates is recognized in income in the period that includes the
enactment date. There were no current or deferred income tax expense or
benefits due to the Company not having any material operations for the period
ended December 31, 2005.

G. Basic Loss Per Common Share

Basic loss per common share has been calculated based on the weighted average
number of shares outstanding during the period after giving retroactive effect
to stock splits. There are no dilutive securities at December 31, 2005 for
purposes of computing fully diluted earnings per share.

H. Stock Based Compensation

The Company accounts for stock options issued to employees in accordance with
the provisions of the Accounting Principles Board ("APB") Opinion No. 25,
"Accounting for Stock Issued to Employees," and related interpretations. As
such, compensation cost is measured on the date of grant as the excess of the
current market price of the underlying stock over the exercise price. Such
compensation amounts, if any, are amortized over the respective vesting periods
of the option grant. The Company adopted the disclosure provisions of SFAS No.
123, "Accounting for Stock-Based Compensation" and SFAS 148, "Accounting for
Stock-Based Compensation -Transition and Disclosure", which permits entities to
provide pro forma net income (loss) and pro forma earnings (loss) per share
disclosures for employee stock option grants as if the fair-valued based method
defined in SFAS No. 123 had been applied. The Company accounts for stock
options and stock issued to non-employees for goods or services in accordance
with the fair value method of SFAS 123.

I. Impact of New Accounting Standards

In December 2004, the FASB issued SFAS No. 123(R), "Share-Based Payment".
SFAS 123(R) is a revision of SFAS No., 123, "Accounting for Stock Based
Compensation," and supersedes Accounting Principles Board Opinion No. 25 ("APB
25"), "Accounting for Stock Issued to Employees." Among other items SFAS 123(R)
eliminates the use of APB 25 and the intrinsic value method of accounting, and
requires companies to recognize the cost of employee services received in
exchange for awards of equity instruments, based on the grant date fair value
of those awards, in the financial statements. The effective date of SFAS 123
(R) is the first annual reporting period beginning after June 15, 2005. The
adoption of SFAS 123 (R) is not expected to have a material impact on the
Company's financial position, results of operations or cash flows.

In March 2005, the SEC staff issued additional guidance on SFAS 123 (R) in
the form of Staff Accounting Bulletin ("SAB") No. 107. SAB 107 was issued to
assist preparers by simplifying some of the implementation challenges of FAS
123 (R) while enhancing the information that investors receive. SAB 107 creates
a framework that is premised on two themes: (a) considerable judgment will be
required by preparers to successfully implement FAS 123 (R), specifically when
valuing employee stock options; and (b) reasonable individuals, acting in good
faith, may conclude differently on the fair value of employee share options.
Key topics covered by SAB 107 include: (a) valuation models - SAB 107
reinforces the flexibility allowed by FAS 123 (R) to choose an option-pricing
model that meets the standard's fair value measurement objective; (b) expected
volatility - the SAB provides guidance on when it would be appropriate to rely
exclusively on either historical or implied volatility in estimating expected
volatility; and (c) expected term - the new guidance includes examples and some
simplified approaches to determining the expected term under certain
circumstances. The Company will apply the principles of SAB 107 in conjunction
with its adoption of SFAS 123 (R) but does not believe its adoption will have
material impact on the Company's financial statements or results of operations.

In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary
Assets, an amendment of APB Opinion No. 29. SFAS No. 153 addresses the
measurement of exchanges of nonmonetary assets and redefines the scope of
transactions that should be measured based on the fair value of the assets
exchanged. SFAS No. 153 is effective for nonmonetary asset exchanges occurring
in fiscal periods beginning after June 15, 2005. The adoption of SFAS No. 153
did not have a material impact on the Company's financial statements or results
of operations.

In January 2003, the FASB issued FASB Interpretation No. 46, ("FIN 46"),
Consolidation of Variable Interest Entities ("VIE"). Until this interpretation,
the Company generally included entities in its consolidated financial
statements only if it controlled the entity through voting interests. FIN No.
46 requires a variable interest entity, as defined, to be consolidated by a
company if that company is subject to a majority of the risk of loss from the
variable interest entity's activities or entitled to receive a majority of the
entity's residual returns. FIN No. 46 is effective for reporting periods ending
after December 15, 2003. The adoption of FIN No. 46 did not have a material
impact on the Company's Consolidated Financial Statements as of December 30,
2005.

In March 2005, FASB issued FASB Interpretation ("FIN") No. 47, "Accounting
for Conditional Asset Retirement Obligations." FIN 47 clarifies that the term
"Conditional Asset Retirement Obligation" as used in FASB Statement No. 143,
"Accounting for Asset Retirement Obligation," refers to a legal obligation to
perform an asset retirement activity in which the timing and/or method of
settlement are conditional on a future event that may or may not be within the
control of the entity. Accordingly, an entity is required to recognize a
liability for the fair value of a Conditional Asset Retirement Obligation if
the fair value of the liability can be reasonably estimated. FIN 47 is
effective no later than the end of fiscal years ending after December 15, 2005.
Management does not believe the adoption of FIN 47 will have a material affect
on the Company's financial position, results of operations or cash flows. In
May 2005, the Financial Accounting Standards Board ("FASB") issued SFAS No.
154, Accounting Changes and Error Corrections ("SFAS No. 154"), which replaced
Accounting Principles Board Opinion No. 20, Accounting Changes and SFAS No. 3,
Reporting Accounting Changes in Interim Financial Statements. SFAS No. 154
changes the requirements for the accounting for and reporting of a change in
accounting principles. It requires retrospective application to prior periods'
financial statements of changes in accounting principles, unless it is
impracticable to determine either the period-specific effects or the cumulative
effect of the change. This statement is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2005.
The impact on the Company's operations will depend on future accounting
pronouncements or changes in accounting principles.

In November 2004, the Financial Accounting Statements Board (FASB) issued
SFAS Statement No. 151, "Inventory Costs," an amendment of the Accounting
Research Bulletin (ARB) No. 43, Chapter 4. Under FASB Statement No. 151, all
abnormal amounts of idle facility expense, freight, handling costs, and wasted
materials (spoilage) should be recognized as current-period charges by
requiring the allocation of fixed production overheads to inventory based on
the normal capacity of the production facilities. The adoption of this
pronouncement is not expected to have a material impact on the Company's
financial statements, results of operations, or cash flows.

In May 2005, the Financial Accounting Standards Board ("FASB") SFAS No. 154,
Accounting Changes and Error Corrections ("SFAS No. 154"), which replaces
Accounting Principles Board Opinion No. 20, Accounting Changes and SFAS No. 3,
Reporting Accounting Changes in Interim Financial Statements. SFAS No. 154
changes the requirements for the accounting for and reporting of a change in
accounting principles. It requires retrospective application to prior periods'
financial statements of changes in accounting principles, unless it is
impracticable to determine either the period-specific effects or the cumulative
effect of the change. This statement is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2005.
The impact on the Company's operations will depend on future accounting
pronouncements or changes in accounting principles.

J. Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet credit exposure related to
its customers.

NOTE 3 GOING CONCERN

The Company's financial statements are prepared using accounting principles
generally accepted in the United States of America applicable to a going
concern that contemplates the realization of assets and liquidation of
liabilities in the normal course of business. The Company has not established
any source of revenue to cover its operating costs. The Company will engage in
very limited activities without incurring any liabilities that must be
satisfied in cash until a source of funding is secured. The Company will offer
noncash consideration and seek equity lines as a means of financing its
operations. If the Company is unable to obtain revenue producing contracts
or financing or if the revenue or financing it does obtain is
insufficient to cover any operating losses it may incur, it may substantially
curtail or terminate its operations or seek other business opportunities
through strategic alliances, acquisitions or other arrangements that may
dilute the interests of existing stockholders.

NOTE 4 SHAREHOLDER'S EQUITY

On July 27, 2004 (inception), the Board of Directors issued 148,000
shares of common stock for $148 in services to the founding shareholder of the
Company to fund organizational start-up costs.

On February 23, 2005, the Board of Directors issued 11,500,000 shares of
common stock for $11,500 in services rendered to an officer and director of the
Company.

Common Stock

The holders of the Company's common stock:

* Have equal ratable rights to dividends from funds legally available
for payment of dividends when, as and if declared by the board of directors;

* Are entitled to share ratably in all of the assets available for
distribution to holders of common stock upon liquidation, dissolution or
winding up of our affairs;

* Do not have preemptive, subscription or conversion rights, or
redemption or access to any sinking fund; and

* Are entitled to one non-cumulative vote per share on all matters
submitted to stockholders for a vote at any meeting of stockholders.

Preferred Stock

The Company has authorized, but not issued, 20,000,000 shares of
preferred stock at $.001 per share. The board of directors has the authority to
establish and fix the designation, powers, or preferences of preferred shares
without further vote by the shareholders.

NOTE 12 SUBSEQUENT EVENTS

On May 8, 2006, an agreement and plan of reorganization among Echelon
Acquisition Corp., a corporation organized under the laws of the State of
Delaware (the "EAC"); Asia Biotechnology Group Inc., a corporation organized
under the laws of British Virgin Islands (the "ABG"); Far Grand Investments
Limited, a corporation organized under the laws of Cayman Islands, acting as
the shareholder of ABG, (the "ABG Shareholder"); Harbin OT Pharmaceutical Co.,
Limited, a company organized under the laws of Samoa (the "OT Samoa"); and
shareholders of OT Samoa ( collectively the "OT Samoa Shareholders").

The respective Boards of Directors of EAC, ABG and OT Samoa have adopted
resolutions pursuant to which all of the issued and outstanding shares of the
common stock of ABG (the "ABG Share") and all of the issued and outstanding
shares of OT Samoa (the "OT Samoa Shares") will be converted into the right to
receive a specified number of shares of the common stock of EAC (the "EAC
Shares"); and whereas, the sole consideration for the exchange of the ABG
Share shall be the receipt by the ABG Shareholder of 23,296,000 EAC Shares,
$0.001 par value per share; and the sole consideration for the exchange of the
OT Samoa Shares shall be the receipt by the OT Samoa Shareholders of 23,296,000
EAC Shares, $0.001 par value per share.

The ABG Shareholder and the OT Samoa Shareholders individually agrees to
transfer to EAC at the closing (the "Closing") the ABG Share and OT Samoa
Shares, in exchange for newly issued and restricted shares of common stock of
EAC. In connection with the acquisition of the ABG Share and the OT Samoa
Shares, EAC shall issue to the ABG Shareholder an aggregate of Twenty Three
Million Two Hundred and Ninety Six Thousand (23,296,000) shares of EAC common
stock, and shall simultaneously issue to the OT Samoa Shareholders an aggregate
of Twenty Three Million Two Hundred and Ninety Six Thousand (23,296,000) shares
of EAC common stock. Such shares at the Closing shall equal eighty percent
(80%) of the issued and outstanding shares of EAC. After the Closing, there
will be 58,240,000 outstanding shares of common stock of the reorganized EAC.

ABG and OT Samoa both became Echelon's wholly owned subsidiaries and the
former shareholders of ABG ("shareholders") obtained effective operating
control of the combined company after the share exchange. Generally accepted
accounting principles require that ABG whose shareholders retain the majority
interest in a combined business be treated as the acquirer for accounting
purpose, resulting in a reverse acquisition. Accordingly, the share exchange
transaction has been accounted for as a recapitalization of Echelon. The equity
section of future financial statements will be been restated to reflect the
recapitalization of Echelon due to the reverse acquisition as of the first day
of the first period presented.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To The Board of Directors
Asia Biotechnology Group Inc.
Beijing, PRC

We have audited the accompanying consolidated balance sheet of Asia
Biotechnology Group Inc. as of December 31, 2005, and the related consolidated
statements of operations and comprehensive loss, shareholders' equity
(deficit), and cash flows for the period from March 21, 2005 (Date of
Inception) to December 31, 2005. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these consolidated financial statements based on our audits.

In our opinion, the consolidated financial statements referred to above present
fairly, in all material respects, the consolidated financial position of Asia
Biotechnology Group Inc. as of December 31, 2005, and the results of its
operations and its cash flows for the period from March 21, 2005 (Date of
Inception) to December 31, 2005, in conformity with accounting principles
generally accepted in the United States of America.

Child, Van Wagoner & Bradshaw, PLLC
Salt Lake City, Utah
May 8, 2006

ASIA BIOTECHNOLOGY GROUP INC.

CONSOLIDATED BALANCE SHEET

December 31,
2005
------------

ASSETS

Current assets
Cash and cash equivalents $ 459,310
Accounts receivable, less allowances for
doubtful accounts of $ 36,095. 426,124
Inventories 247,314
Prepaid expense - reorganization expense 315,000
Other current assets 20,087
------------
Total current assets 1,467,835

Property, plant and equipment, net 860,021
Land use right, net 100,362
------------
Total assets $ 2,428,218
============

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities
Accounts payable $ 107,658
Accrued expenses 13,385
Customer deposits 354,010
Due to shareholders 1,577,050
Other current liabilities 6,047
------------
Total current liabilities 2,058,150

Minority interests 434,032

Shareholders' deficit
Ordinary share, par value $1 per share;
authorized 50,000 shares, shares issued and
outstanding 1 share 1
Accumulated deficit (64,052)
Accumulated other comprehensive income 87
------------
Total shareholders' deficit (63,964)
------------
Total liabilities and shareholders' deficit $ 2,428,218
============

See accompanying notes to consolidated financial statements.

ASIA BIOTECHNOLOGY GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

March 21, 2005
(Date of Inception) to
December 31, 2005

Net sales $ 37,972

Cost of sales 32,214
--------------
Gross profit 5,758

Operating expenses
Allowance for bad debt 3,614
Accounting and audit fee 45,000
Salaries 8,154
Depreciation 4,549
Amortization of land use right 373
Other selling, general and administrative 31,420
--------------
Total operating expenses 93,110
--------------
Loss from operations (87,352)

Non-Operating Income
Government Grant 10,618
Interest income 47
--------------
Total Non-Operating Expenses 10,665
--------------
Loss before income taxes and minority interests (76,687)

Income taxes -
--------------
Loss before minority interests (76,687)
--------------
Minority interests 12,635

Net loss $ (64,052)
==============
Other comprehensive income
Foreign currency translation adjustment 87
--------------

Comprehensive loss $ (63,965)
==============

Loss per share - basic and diluted $ (64,052)
==============

Weighted average shares outstanding - basic and diluted 1
==============

See accompanying notes to consolidated financial statements.

ASIA BIOTECHNOLOGY GROUP INC.

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD FROM MARCH 21, 2005 (DATE OF INCEPTION)
TO DECEMBER 31, 2005

ACCUMULATED OTHER TOTAL
ORDINARY SHARE ADDITIONAL
SHARES PAID-IN ACCUMULATED COMPREHENSIVE SHAREHOLDERS'
OUTSTANDING AMOUNT CAPITAL DEFICIT INCOME EQUITY (DEFICIT)

Share capital 1 $ 1 $ - $ - $ - $ 1
Net loss (64,052) (64,052)
Foreign currency translation gain
87 87
------------------------------------------------------------------------------
Balance at December 31, 2005 1 $ 1 $ - $ (64,052) $ 87 $ (63,964)
==============================================================================

See accompanying notes to consolidated financial statements.

ASIA BIOTECHNOLOGY GROUP INC.

CONSOLIDATED STATEMENT OF CASH FLOW
FOR THE PERIOD FROM MARCH 21, 2005 (DATE OF INCEPTION)
TO DECEMBER 31, 2005

March 21, 2005 (Date of
Inception) to
December 31, 2005
-----------------

Cash flows from operating activities
Net loss $ (64,052)
Adjustment to reconcile net income to net cash used in
operating activities:
Depreciation and amortization of property, plant and equipment 18,284
Minority interests share of net loss (12,635)
Changes in current assets and liabilities (net of effects of acquisitions and disposals
of entities)
Accounts receivable 30,660
Inventories 4,091
Prepaid expense - reorganization expense (315,000)
Other current assets (10,693)
Accounts payable 5,732
Accrued expenses 1,696
Customer deposits 11,572
Other current liabilities (13,467)
-----------------
Net cash used in operating activities (343,812)

Cash flows from investing activities
Capital expenditure (13,151)
Cost of investment in subsidiary, net of cash acquired in acquisition (666,389)
-----------------
Net cash used in investing activities (679,540)

Cash flows from financing activities
Proceeds from share capital 1
Advances from shareholders 1,482,574
-----------------
Net cash provided by financing activities 1,482,575

Effect of foreign currencies on cash flows 87
-----------------
Net increase in cash and cash equivalents 459,310
Cash and cash equivalents, beginning of period -
-----------------
Cash and cash equivalents, end of period $ 459,310
=================

See accompanying notes to consolidated financial statements.

NOTE 1 ORGANIZATION

Asia Biotechnology Group Inc. ("the Company" or "Asia Biotechnology" or
"ABG") is a limited liability company registered under the laws of the British
Virgin Islands and was incorporated in British Virgin Islands on March 21,
2005.

Asia Biotechnology is an investment holding and it acquired 60%
shareholding of a company called Harbin OT Pharmaceutical Co. Ltd. ("OT China")
on November 3, 2005. All activities of the Group are principally conducted by
subsidiary company operating in the People's Republic of China ("PRC").

Harbin OT Pharmaceutical Company Limited is a Chinese foreign owned
enterprise incorporated in the People's Republic of China ("PRC") on April 13,
2001. The Company is a feminine suppository manufacturer and provides this
suppository to clinics and the Red Cross Society of China.

NOTE 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A. Basis of presentation

The consolidated financial statements include the accounts of Asia
Biotechnology Group Inc. and Harbin OT Pharmaceutical Company Limited. All
material intercompany accounts and transactions have been eliminated in
consolidation.

B. Fiscal year

These financial statements have been prepared using December 31 as the
fiscal year end.

C. Minority interest in subsidiary

The Company records minority interest expense, which reflects the minority
shareholders' 40% portion of the earnings or loss of Harbin OT Pharmaceutical
Company Limited.

D. Control by principal stockholders

The directors, executive officers and their affiliates or related parties
own, beneficially and in the aggregate, the majority of the voting power of
the outstanding shares of the common stock of the Company. Accordingly, the
directors, executive officers and their affiliates, if they voted their shares
uniformly, would have the ability to control the approval of most corporate
actions, including increasing the authorized capital stock of the Company and
the dissolution, merger or sale of the Company's assets.

E. Cash and cash equivalents

Cash and cash equivalents include cash on hand, cash accounts, interest bearing
savings accounts and time certificates of deposit with a maturity of three
months or less when purchased.

F. Inventories

Inventories are stated at the lower of cost or market, determined by the
weighted average method. Finished goods inventories consist of raw materials,
direct labor and overhead associated with the manufacturing process.

G. Trade accounts receivable

Trade accounts receivable are recorded at the invoiced amount and do not
bear interest. The allowance for doubtful accounts represents the Company's
best estimate of the amount of probable credit losses in the existing accounts
receivable balance. The Company determines the allowance for doubtful accounts
based upon historical write-off experience and current economic conditions. The
Company reviews the adequacy of its allowance for doubtful accounts on a
regular basis. Account balances are charged off against the allowance after all
means of collection have been exhausted and the potential for recovery is
considered remote. The Company signed a sales contract with Red Cross Society
of China with the terms of payment is over than one year.

H. Credit Risk and Customers

The Company has a concentration of customers. The Company is diligent in
attempting to ensure that the issue credit to credit-worthy customers. However,
the customer base is small and our accounts receivable balances are usually
over 90 days outstanding, and that exposes us to significant credit risk.
Therefore, a credit loss can be very large relative to our overall
profitability. Concentration of credit risk with respect to accounts receivable
is limited to a single customer, the Red Cross Society of China to whom the
Company makes substantial sales. The Red Cross Society of China is the only
receivable of the Company. The Company regularly monitors the creditworthiness
of its customers and believes that it has adequately provided for exposure to
potential credit losses.

I. Property, plant and equipment

Property, plant and equipment are stated at cost including the cost of
improvements. Depreciation and amortization are provided on the straight-line
method based on the estimated useful lives of the assets as follows:

Buildings 20 years
Leasehold improvements 20 years
Plant and machinery 10 years
Motor vehicles 5 years
Furniture, fixtures and equipment 5 years

J. Valuation of long-lived assets

The Company periodically evaluates the carrying value of long-lived assets to
be held and used, including intangible assets subject to amortization, when
events and circumstances warrant such a review. The carrying value of a long-
lived asset is considered impaired when the anticipated undiscounted cash flow
from such asset is separately identifiable and is less than its carrying value.
In that event, a loss is recognized based on the amount by which the carrying
value exceeds the fair market value of the long-lived asset. Fair market value
is determined primarily using the anticipated cash flows discounted at a rate
commensurate with the risk involved. Losses on long-lived assets to be
disposed of are determined in a similar manner, except that fair market values
are reduced for the cost to dispose.

A. Revenue recognition

The Company recognizes revenue when it is realized and earned. The Company
considers revenue realized or realizable and earned when (1) it has persuasive
evidence of an arrangement, (2) delivery has occurred, (3) the sales price is
fixed or determinable, and (4) collectibility is reasonably assured. Delivery
does not occur until products have been shipped to the client, risk of loss has
transferred to the client and client acceptance has been obtained, client
acceptance provisions have lapsed, or the Company has objective evidence that
the criteria specified in client acceptance provisions have been satisfied.
The sales price is not considered to be fixed or determinable until all
contingencies related to the sale have been resolved.

L. Comprehensive income (loss)

Comprehensive income (loss) includes changes to equity accounts that were not
the result of transactions with shareholders. Comprehensive income (loss) is
comprised of net income (loss) and other comprehensive income and loss items.
The Company's comprehensive income and losses generally consist of changes in
the fair value of changes in the cumulative foreign currency translation
adjustment.

M. Foreign currency translation

The Company has determined the PRC Chinese Yuan Renminbi to be the functional
currency of the Company. The financial statements of the Company are translated
to United States dollars using year-end rates of exchange for assets and
liabilities, and average rates of exchange for the period for revenues, costs,
and expenses. Net gains and losses resulting from foreign exchange transactions
are included in the consolidated statements of operations. The cumulative
translation adjustment and effect of exchange rate changes at December 31, 2005
were $87.

N. Stockholder Loan

The caption "Due to shareholders" on the consolidated Balance Sheet consists of
loans that are unsecured, non-interest bearing and have no fixed terms of
repayment, and therefore, are deemed payable on demand.

O. Use of estimates

A. Significant Estimates

Q. Income Taxes

The Company accounts for income taxes under the Financial Accounting Standards
Board (FASB) Statement No. 109, "Accounting for Income Taxes" "Statement
109"). Under Statement 109, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and
their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in
which those temporary differences are expected to be recovered or settled.
Under Statement 109, the effect on deferred tax assets and liabilities of a
change in tax rates is recognized in income in the period that includes the
enactment date.

R. Basic Loss Per Common Share

Basic loss per common share has been calculated based on the weighted average
number of shares outstanding during the period.

S. Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet credit exposure related to
its customers.

NOTE 3 INVENTORIES

Inventories by major categories, consist of the following at December 31, 2005:

Raw materials $ 182,250
Finished goods 26,846
Packaging materials 38,218
----------
$ 247,314
==========

NOTE 4 PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment, which is all located in the PRC, consist of the
following at December 31, 2005:

At cost:
Buildings $ 828,87
Leasehold improvements 51,375
Plant and machinery 298,042
Motor vehicles 83,921
Furniture, fixtures and equipment 44,012
---------
Total 1,306,22
Less: accumulated depreciation and amortization (446,200)
---------
Net book value $ 860,02
=========

NOTE 5 LAND USE RIGHT

Land use right for the land located in PRC, consists of the following at
December 31, 2005:

Land Use Right, cost $ 110,718
Less: accumulated amortization (10,356)
-----------
Net book value $ 100,362
===========

All the land in the PRC is owned by the PRC government. The government,
according to PRC laws, may grant to entities the right to use of land for a
specified period of time. Thus all of the Company's land occupied in the PRC is
considered to be leasehold land and amortized on a straight-line basis over the
respective term of the right to use the land.

The subsidiary, OT China is granted the right to use of land for 50
years and is amortized on a straight-line basis over 50 years of the right to
use the land from the date of acquisition in 2001.

NOTE 6 INTELLECTUAL PROPERTY

The subsidiary, OT China, owns patent rights and technical know-how
which were contributed by minority shareholders. The costs to the minority
shareholder for obtaining the patent right were not recorded on the balance
sheet as the patent application costs were not significant.

NOTE 7 BUSINESS ACQUISITION

On November 3, 2005, the Company obtained a 60% interest in Harbin OT
Pharmaceutical Co. Ltd. for $670,000 in cash.

The fair value of assets acquired are as follows:

Cash $ 3,611
Accounts receivable 430,215
Inventory 277,973
Prepaid expenses 9,395
Property, plant and equipment 965,515
Due to shareholder (94,477)
Liabilities assumed (475,565)
-----------
Net assets 1,116,667
Less: minority interest @ 40% 446,667
-----------
Net assets purchased $ 670,000
===========

The financial statements for the period from March 21, 2005 (Date of
Inception) to December 31, 2005 include the results of operations of the
acquired company for the period November 3, 2005 to December 31, 2005.

NOTE 8 INCOME TAXES

The Company accounts for income taxes in accordance with the provisions of SFAS
No. 109, "Accounting for Income Taxes."

Income tax expense is based on reported income before income taxes. Deferred
income taxes reflect the effect of temporary differences between assets and
liabilities that are recognized for financial reporting purposes and the
amounts that are recognized for income tax purposes. In accordance with SFAS
109, these deferred income taxes are measured by applying currently enacted tax
laws.

BRITISH VIRGIN ISLANDS

The Company is incorporated in the British Virgin Islands and, under the
current laws of the British Virgin Islands, is not subject to income taxes.

PRC

Enterprises income tax in PRC is generally charged at 33%, in which 30% is for
national tax and 3% is for local tax, of the assessable profit. The Company
incorporated in PRC are subject to PRC enterprises income tax at the applicable
tax rates on the taxable income as reported in their Chinese statutory accounts
in accordance with the relevant enterprises income tax laws applicable to
foreign enterprises. Pursuant to the same enterprises income tax laws, the
subsidiaries are fully exempted from PRC enterprises income tax for two years
starting from the first profit-making year, followed by a 50% tax exemption for
the next three years.

According to the PRC's applicable income tax laws, regulations, notices and
decisions related to foreign investment enterprises and their investors, income
such as dividends and profits distribution from the PRC derived from a foreign
enterprise which has no establishment in the PRC is subject to a 10%
withholding tax.

There are net operating loss carryforwards allowed under the China's
governments' tax systems. In China, the previous five years net operating
losses are allowed to be carryforward five years to offset future taxable
income. The Company has available approximately $ 1,100,000 of unused operating
loss carryforwards and based on a 33% tax rate has a deferred tax asset of
approximately $363,000 in which the company recorded a valuation allowance for
the same amount at December 31, 2005.

The company withholds and pays income taxes on its employees' wages, which
funds the Chinese government's sponsored health and retirement programs of all
the employees.

NOTE 9 SHAREHOLDERS' EQUITY

The Company was incorporated with an authorized share capital of $50,000
divided into 50,000 shares of $1 each.

1 subscribers' share was issued on inception of the Company.

NOTE 10 EMPLOYEE BENEFITS

The Company has established its own employee welfare plan in accordance
with Chinese law and regulations. The Company makes annual contributions of 14%
of all employees' salaries to its employee welfare plan. The total expenses for
the above plan were $1,142 for the period from March 21, 2005 (Inception Date)
to December 31, 2005. The Company has recorded welfare payments in the amount
of $13,385 as of December 31, 2005 in balance sheet.

NOTE 11 RECENT ACCOUNTING PRONOUNCEMENTS

In December 2004, the FASB issued SFAS No. 123(R), "Share-
Based Payment". SFAS 123(R) is a revision of SFAS No., 123, "Accounting for
Stock Based Compensation," and supersedes Accounting Principles Board Opinion
No. 25 ("APB 25"), "Accounting for Stock Issued to Employees." Among other
items SFAS 123(R) eliminates the use of APB 25 and the intrinsic value method
of accounting, and requires companies to recognize the cost of employee
services received in exchange for awards of equity instruments, based on the
grant date fair value of those awards, in the financial statements. The
effective date of SFAS 123 (R) is the first annual reporting period beginning
after June 15, 2005. The adoption of SFAS 123 (R) is not expected to have a
material impact on the Company's financial position, results of operations or
cash flows.

In March 2005, the SEC staff issued additional guidance on SFAS 123 (R)
in the form of Staff Accounting Bulletin ("SAB") No. 107. SAB 107 was
issued to assist preparers by simplifying some of the implementation challenges
of FAS 123 (R) while enhancing the information that investors receive. SAB 107
creates a framework that is premised on two themes: (a) considerable judgment
will be required by preparers to successfully implement FAS 123 (R),
specifically when valuing employee stock options; and (b) reasonable
individuals, acting in good faith, may conclude differently on the fair value
of employee share options. Key topics covered by SAB 107 include: (a) valuation
models - SAB 107 reinforces the flexibility allowed by FAS 123 (R) to choose an
option-pricing model that meets the standard's fair value measurement
objective; (b) expected volatility - the SAB provides guidance on when it would
be appropriate to rely exclusively on either historical or implied volatility
in estimating expected volatility; and (c) expected term - the new guidance
includes examples and some simplified approaches to determining the expected
term under certain circumstances. The Company will apply the principles of SAB
107 in conjunction with its adoption of SFAS 123 (R) but does not believe its
adoption will have material impact on the Company's financial statements or
results of operations.

In December 2004, the FASB issued SFAS No. 153, Exchanges of
Nonmonetary Assets, an amendment of APB Opinion No. 29. SFAS No. 153 addresses
the measurement of exchanges of nonmonetary assets and redefines the scope of
transactions that should be measured based on the fair value of the assets
exchanged. SFAS No. 153 is effective for nonmonetary asset exchanges occurring
in fiscal periods beginning after June 15, 2005. The adoption of SFAS No. 153
did not have a material impact on the Company's financial statements or results
of operations.

In March 2005, FASB issued FASB Interpretation ("FIN") No. 47,
"Accounting for Conditional Asset Retirement Obligations." FIN 47 clarifies
that the term "Conditional Asset Retirement Obligation" as used in FASB
Statement No. 143, "Accounting for Asset Retirement Obligation," refers to a
legal obligation to perform an asset retirement activity in which the timing
and/or method of settlement are conditional on a future event that may or may
not be within the control of the entity. Accordingly, an entity is required to
recognize a liability for the fair value of a Conditional Asset Retirement
Obligation if the fair value of the liability can be reasonably estimated. FIN
47 is effective no later than the end of fiscal years ending after December 15,
2005. Management does not believe the adoption of FIN 47 will have a material
affect on the Company's financial position, results of operations or cash
flows. In May 2005, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 154, Accounting Changes and Error Corrections ("SFAS No. 154"), which
replaced Accounting Principles Board Opinion No. 20, Accounting Changes and
SFAS No. 3, Reporting Accounting Changes in Interim Financial Statements. SFAS
No. 154 changes the requirements for the accounting for and reporting of a
change in accounting principles. It requires retrospective application to prior
periods' financial statements of changes in accounting principles, unless it is
impracticable to determine either the period-specific effects or the cumulative
effect of the change. This statement is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2005.
The impact on the Company's operations will depend on future accounting
pronouncements or changes in accounting principles.

In November 2004, the Financial Accounting Statements Board (FASB)
issued SFAS Statement No. 151, "Inventory
Costs," an amendment of the Accounting Research Bulletin (ARB) No. 43, Chapter
4. Under FASB Statement No. 151, all abnormal amounts of idle facility expense,
freight, handling costs, and wasted materials (spoilage) should be recognized
as current-period charges by requiring the allocation of fixed production
overheads to inventory based on the normal capacity of the production
facilities. The adoption of this pronouncement is not expected to have a
material impact on the Company's financial statements, results of operations,
or cash flows.

In May 2005, the Financial Accounting Standards Board ("FASB") SFAS No.
154, Accounting Changes and Error Corrections ("SFAS No. 154"), which replaces
Accounting Principles Board Opinion No. 20, Accounting Changes and SFAS No. 3,
Reporting Accounting Changes in Interim Financial Statements. SFAS No. 154
changes the requirements for the accounting for and reporting of a change in
accounting principles. It requires retrospective application to prior periods'
financial statements of changes in accounting principles, unless it is
impracticable to determine either the period-specific effects or the cumulative
effect of the change. This statement is effective for accounting changes and
corrections of errors made in fiscal years beginning after December 15, 2005.
The impact on the Company's operations will depend on future accounting
pronouncements or changes in accounting principles.

NOTE 12 SUBSEQUENT EVENTS

ABG and OT Samoa both became Echelon's wholly owned subsidiaries and the former
shareholders of ABG ("shareholders") obtained effective operating control of
the combined company after the share exchange. Generally accepted accounting
principles require that ABG whose shareholders retain the majority interest in
a combined business be treated as the acquirer for accounting purpose,
resulting in a reverse acquisition. Accordingly, the share exchange transaction
has been accounted for as a recapitalization of Echelon. The equity section of
the future financial statements will be restated to reflect the
recapitalization of Echelon due to the reverse acquisition as of the first day
of the first period presented.